Home › Heart Failure › Vermont
Heart Failure clinical trials in Vermont
8 studies for Heart Failure are looking for participants at sites in Vermont.
Cities in Vermont
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Burlington
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Burlington, VT Investigative Site 10053, Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Burlington
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180ELEVATE-HFpEF Clinical Study
- The University of Vermont Medical Center, Burlington
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10053, Burlington, VT, Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Vermont, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487His-Bundle Corrective Pacing in Heart Failure
- University of Vermont, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT05265520Left vs Left Randomized Clinical Trial
- University of Vermont, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05650658From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.